Dose-Dependent GI Side Effects Studies show that gastrointestinal side effects are most frequent and intense during the early stages of GLP-1 receptor agonist therapy and are largely dose-dependent. This isnt a sign that the medication is harming the body
Furthermore, malignant insulinomas frequently downregulate GLP-1R, with approximately two-thirds of cases exhibiting a switch to predominant somatostatin receptor expression [354, 510]
But desperate times, you know
The increase in thigmotaxis (time spent close to the walls) following psilocybin-treatment could be interpreted as anxiogenic [34], but in this instance, seems to relate to reduced total locomotion
Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K
How long will I need to be on GLP-1 medication